# Oslo Pharmacist Intervention Study - Effect on Readmissions

> **NCT02336113** · NA · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Acute Admitted Multimorbid Patients

## Interventions

- **BEHAVIORAL:** multidisciplinary treatment

## Key facts

- **NCT ID:** NCT02336113
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2018-07-06
- **Final completion:** 2020-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2020-03-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336113, "Oslo Pharmacist Intervention Study - Effect on Readmissions". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02336113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*